Herbal Medicines and Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study.
Background. The aim of this study was to assess the association between herbal medication and OHSS. Methods. This retrospective cohort study was conducted with 101 polycystic ovary syndrome patients. 66 patients took conventional pharmacological medications and 35 took herbal medications. Data were analyzed by statistical test including Fisher's Exact and binominal logistic regression. P < 0.05 was considered significant. Results. Of the 101 females, 53 were married and 48 were single. There was no significant association between the groups in marriage. No significant association was found in mean age between the two groups (23.9 ± 5.8 years in the control group versus 26.3 ± 6.7 years in the case group). There was a significant difference between the two groups .After adding the dependent (OHSS prevalence) and independent (marriage and group) variables into the model, the Hosmer-Lemeshow test showed suitability. Variances analyzed with this model ranged between 29.4% and 40.7%. Conclusion. The indiscriminate use of herbs is correlated with OHSS. Because patients increasingly consume herbs, they should be aware of potential side effects. However, appropriate dosages of herbs could be obtained for use instead of conventional treatments, which often have side effects.
Obstetrics and Gynecology Department, Jahrom University of Medical Sciences, Jahrom, Iran.
Athar
A
Rasekhjahromi
Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Masoumeh
0000-0002-1754-2119
M
Hosseinpoor
Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Farzaneh
F
Alipour
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehrnoosh
M
Maalhagh
Department of Community Health, Jahrom University of Medical Sciences, Jahrom, Iran.
Saeed
S
Sobhanian
Br J Anaesth. 2002 Nov;89(5):792-5
12393786
Bull Environ Contam Toxicol. 2000 Jul;65(1):112-9
10874088
Aliment Pharmacol Ther. 2000 Dec;14(12):1671-7
11121917
Hum Reprod. 2002 May;17(5):1212-6
11980740
Pain Med. 2011 Dec;12(12):1808-18
22054010
PLoS One. 2013 Dec 10;8(12):e81650
24339951
Hum Reprod. 1991 Nov;6(10):1395-9
1770133
BMC Med. 2011 Aug 09;9:94
21827684
Diabetes Care. 2008 Jan;31(1):41-3
17909085
Fertil Steril. 1978 Sep;30(3):255-68
361440
Planta Med. 1979 Oct;37(2):115-23
117474
N Engl J Med. 2003 Aug 21;349(8):760-6
12930928
Fertil Steril. 2004 Aug;82(2):415-20
15302292
Curr Health Sci J. 2013 Jan;39(1):20-5
24778852
Lancet. 2007 Aug 25;370(9588):685-97
17720020
Mol Med Rep. 2010 Nov 1;3(6):895-901
21132119
J Clin Pharmacol. 2002 Jul;42(7):731-7
12092740
Hum Reprod Update. 2002 Nov-Dec;8(6):559-77
12498425
Crit Care Med. 2005 Oct;33(10 Suppl):S301-6
16215351
Cancer Lett. 1993 Aug 16;72(1-2):5-9
8402574
J Exp Clin Assist Reprod. 2009 Jun 10;6:3
20485578
Fertil Steril. 2007 Jul;88(1):240-3
17296187
J Ovarian Res. 2013 Nov 05;6(1):77
24191960
Obstet Gynecol. 2001 Apr;97(4):577-82
11275030